Breast cancer; screening or overdiagnosis? Questioning of a family doctor

Similar documents
Why the results from the EUROSCREEN Working Group are false

SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY

SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY

Screening Mammography Policy and Politics. Kevin L. Piggott, MD, MPH August 29, 2015

Breast Cancer Screening

Breast Screening: risks if you do and risks if you don t. Stephen W. Duffy Wolfson Institute of Preventive Medicine

OVERDETECTION INFORMATION IN A BREAST CANCER SCREENING DECISION AID

IL Balance Sheet dei programmi di screening mammografici dell Unione Europea

Screening for non-communicable diseases: the intended benefits and the unintended harms

Screening for Breast Cancer

BMC Women's Health. Open Access. Abstract

Epidemiologic Methods for Evaluating Screening Programs. Rosa M. Crum, MD, MHS Johns Hopkins University

Key outcomes for studies on breast cancer screening

How often should I get a mammogram?

General principles of screening: A radiological perspective

Should I Get a Mammogram?

Screening policy across Europe has evolved with regard to its goal: Participation informed participation informed decision for or against

Effective breast cancer screening should reduce the ORIGINAL RESEARCH

Controversies in Breast Cancer Screening

Screening for breast cancer with mammography(review)

Examination of the impact of shifting practice from plain film mammography to digital mammography

The Northern Ireland breast screening programme

BREAST CANCER SCREENING:

Cancer Screening: Evidence, Opinion and Fact Dialogue on Cancer April Ruth Etzioni Fred Hutchinson Cancer Research Center

5/24/16. Current Issues in Breast Cancer Screening. Breast cancer screening guidelines. Outline

Evidence Based Medicine

MethodologicOverview of Screening Studies

Screening Overdiagnosis. Archie Bleyer, MD Department of Radiation Medicine Knight Cancer Institute at the Oregon Health & Science University

Screening: Past and Future perfect? Rosalind Given-Wilson Consultant Radiologist St Georges University Hospitals FT

Screening for cancer in nursing home patients: Almost always a bad idea

Overdiagnosis and Overtreatment of Prostate Cancer and Breast Cancer Due to Screening

Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health

Screening for breast cancer with mammography (Review)

Communicating Risk & Benefit to Health Care Providers & Patients

LESSON 5.2 WORKBOOK. What do cancer screens really tell us? Workbook Lesson 5.2

PSA To screen or not to screen? Darrel Drachenberg, MD, FRCSC

Overdiagnosis of Breast Cancer: Myths and Facts

SBI Breast Imaging Symposium 2016 Austin Texas, April 7, 2016

Health Technology Assessment

Executive summary. The usefulness of breast cancer screening

I can t make a choice if I m not well informed : Ontarians advice for improving provincial screening program materials

Some Controversial Ideas about Cancer Screening. The Hong Kong College of Family Physicians May 29,2009

Cancer screening Pros, cons, choice, and the patient

Effect of Three Decades of Screening Mammography on the Incidence of Breast Cancer

Screening for breast cancer with mammography (Review)

Learning and Earning with Gateway Professional Education CME/CEU Webinar Series. Breast Cancer Screening September 21, :00pm 1:00pm

Patient and Public Involvement in Research

Public and patient values about informed choice and mammography screening: Results from 4 Ontario deliberations

News You Can Use: Recent Studies that Changed My Practice

Stephen W Duffy, Laszlo Tabar, Anne Helene Olsen, Bedrich Vitak, Prue C Allgood, Tony H H Chen, Amy M F Yen and Robert A Smith...

Trends in stage-specific breast cancer incidence and overdiagnosis in NSW

Steven Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute

Update in Breast Cancer Screening

RESEARCH. Breast cancer mortality in organised mammography screening in Denmark: comparative study

2017 Breast Cancer Update

Overdiagnosis or real clinical benefit How to evaluate new diagnostics that challenge existing disease definitions

Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?

Population screening and intervention for vascular disease in Danish men (VIVA): a randomized controlled trial

Prostate Cancer Screening: Risks and Benefits across the Ages

Introduction. Research

Population Prospective. Big Picture

OVERDIAGNOSIS: Making People Sick in the Pursuit of Health

TIME SINCE LAST MAMMOGRAM, AGE 35 YEARS AND OLDER KEY MESSAGES

Breast Cancer Screening Series: Dr. Martin Yaffe

The subject of breast cancer screening is complicated.

Rethinking Breast Cancer Screening

Supplementary appendix

Linking Oncotype Dx results to SEER data and patient report to assess challenges in individualizing breast cancer care

BREAST CANCER SCREENING IS A CHOICE

The effectiveness of breast cancer screening

Cancer Screening Programmes BREAST SCREENING. The Facts

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite

Guidelines in Breast Screening Mammography: Pros and Cons JOSLYN ALBRIGHT, MD SURGICAL ONCOLOGIST, ADVOCATE CHRIST MEDICAL CENTER OCTOBER 1, 2016

SHARED DECISION MAKING FOR PROSTATE CANCER SCREENING

IQWiG Reports - Commission No. A Ezetimibe for hypercholesterolaemia 1. Executive Summary

Screening for breast cancer

Breast Cancer Screening

HTA commissioned call

The Debate: Is screening s effect on mortality significant? Cancer incidence/death/ gender US

Breast Cancer Screening Shared Decision Making

Summary of the BreastScreen Aotearoa Mortality Evaluation

Recommendations on Screening for Lung Cancer 2016

Prostate Cancer. Axiom. Overdetection Is A Small Issue. Reducing Morbidity and Mortality

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures

The undersigned submit this petition under 42 U.S.C. 263b of the Mammogram Quality Standards Advisory Act of 1992 as amended and renewed in the

Screening Mammography as an example of Access to Healthcare A starting point for safe affordable medical treatment. Prof C A Benn

PROPECIA is prescribed for individuals with male pattern baldness.

WHO Perspective on Cancer Screening

Too much treatment for the well, not enough for the sick

U.S. Preventive Services Task Force: Draft Prostate Cancer Screening Recommendation (April 2017)

GENERAL COMMENTS. The Task Force Process Should be Fully Open, Balanced and Transparent

Screening Mammography Among Women With A Family History Of Breast Cancer

Will CT screening reduce overall lung cancer mortality? Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH

Prostate Cancer Screening: Con. Laurence Klotz Professor of Surgery, Sunnybrook HSC University of Toronto

The HPV vaccination programme in Flanders. Geert Top MD Infectious disease control and vaccination

NHS breast screening NHS BCS Fact booklet_aw_cs4.indd 1 29/12/ :51

YOUR VALUES YOUR PREFERENCES YOUR CHOICE. Should You Start Breast Cancer Screenings at Age 40 or 45?

Transcription:

# abstract 1599 Breast cancer; screening or overdiagnosis? Questioning of a family doctor Ibrahim Lassoued & Marc Jamoulle Family practionners, Belgium DUMG ULB & IRSS UCL ibrahim@lassoued.be

Aim The authors have tried to update their knowledge of breast cancer screening by a review of the scientific literature, the recommendations made by various national health institutions as well as expert advices. How to answer? I received this letter summoning me for a mammogram as two years ago. Should I do it?

Methods The current literature has been reviewed, as well as books on the issues of screening, the work of some experts helps to clarify the following points : The potential benefit of routine screening of women aged 50 to 69 years The risks and potential side effects of breast cancer screening by mammography. Informing women invited to screening

Breast Cancer: Epidemiology Belgium cancer registry ; Liesbet Van heyken, Mars 2010 Most common invasive tumors in women Belgium (2006)

Taux standardisés monde pour 100 000 personnes- années Incidence constantly increasing with a stable mortality 120 Cancer du sein: incidence et mortalité estimées en France (1980-2005) 100 80 60 40 20 0 1980 1985 1990 1995 2000 2005 Incidence mortalité Aurélien Belot, estimation nationale de l incidence et de la mortalité par cancer en France entre 1980 et 2005, INVS

Welch HG. Overdiagnosed: Making People Sick in the Pursuit of Health 2012.

Incidence constantly increasing with a stable mortality two hypotheses Effectiveness of screening facing an epidemic of fatal cancers OR very important cancers overdiagnosis

Studies validating the screening are heterogeneous All-Cause Mortality in Randomized Trials of Cancer Screening Journal of the National Cancer Institute,, 2002

Cochrane (2009) Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 2011 7 RCT studied total of 600,000 women If we consider the 3 good quality trials No decrease 10-year specific mortality No reduction in global mortality at 13 years If we consider these 7 RCT (with their bias) a decrease in mortality of 15% was obtained NNS 2000 for 10 years 200 (10%) False Positive 10 (0.5%)) over-diagnosed and treated unnecessarily

Independent UK panel on BCS (2012) for every 10 000 UK women aged 50 years invited to screening for the next 20 years, 43 deaths from breast cancer would be prevented and 129 cases of breast cancer, invasive and non-invasive, would be overdiagnosed Independent UK panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012 Nov 17

Heterogeneity of diseases

Different growing speed Quick or slow grow

And what about our patients? Gotzsche, the fact or may be not; BMJ 2009 Two studies have attempted to assess women's knowledge about mammography screening 92% don t know the risks of overtreatment 68% believe that screening reduces the risk of getting cancer 60% believe that being screened decreases by more than 50% mortality Schwartz LM,US women s attitues to false positive mammography results; BMJ 2000

Role of the family doctor Information Manager for the benefit of our patients for: A clear and accurate information, free from ambiguity Allow patients to decide their choice knowingly Combat false beliefs Each tumor detected is not a fatal cancer Screening don t reduces the number of aggressive treatment Screening don t prevents the occurrence of cancer Explain The risk of false positive & The risk of false negative

The Nordic Cochrane Centre Mammography screening leaflet Available in 15 languages http://www.cochrane.dk/ Gotzsche PG, Hartling OJ, Nielsen M, Brodersen J. Screening for breast cancer with mammography. The Nordic Cochrane Center; 2012. 15p.

Take home message Effectiveness of screening remains debatable (NNS 2000) Reality side effects of mass screening Overdiagnosis, overtreatment, false negative ect. Most women uninformed about the advantages / disadvantages of screening Family doctor privileged interlocutor for clear information and combat false beliefs. Bibliography on Mendeley.com http://tinyurl.com/lassoued